When intensifying T2DM therapy to reach glycemic goals, newer agents target common comorbidities. Which would you choose in these 3 scenarios?
Choice of antihyperglycemic agent after metformin can now be selected to also address comorbidites often seen in T2DM patients. Each of the 3 patients in this short case quiz presents a challenge as well as an opportonity to optimize diabetes care. Â
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.